Search results:


General Information



Gene_Symbol Gene_ID Gene_Name Chromosome Alias
TLR4 7099 Toll-like receptor 4  9TOLL; CD284; TLR-4; ARMD10 







  • Evidence
  • Gene
  • mRNA
  • CDS
  • Protein
  • PTM
  • Enzyme
  • PPi
  • Pathway
  • Structural
  • Domain
  • Ontology
  • SNP
  • Drug
  • External Links



Evidence Information


Pubmed ID Year Sample Information Techniques Mechanism Fold Change Remark
21920464   2011Cell line : -

Source : ATTC, Division of Gastroenterology, Kliniken Essen-Sd (Essen, Germany).

Sample Type : -

No. of Sample : -

Stage : -

-Polymorhpism-Primary human colon cancers carrying the TLR4-D299G variant showed a more progressive tumor stage distribution when compared with TLR4-WT at initial diagnosis.

Significant elevation of the inflammation-/tumor-associated genes STAT3 and Cx43 in association with TLR4-D299G.

22999059   2013Cell line : -

Source : Portuguese Institute of Oncology, Porto (IPOP) and Coimbra (IPOC).

Sample Type : CRC tumor and normal tissue

No. of Sample : 471 participants: 193 histologically confirmed CRC patients and 278 cancer-free controls

Stage : -

polymorphisms genotyping, RT-PCRPolymorhpism-TLR4 299Gly homozygous genotype increasing 3-fold the CRC risk.LR2>C and TLR4 Asp299Gly SNPs significantly influence the risk of CRC development, suggesting that these TLRs SNPs may be genetic susceptibility markers for CRC.

23949880   2014Cell line : -

Source : -

Sample Type : CRC tumor and normal tissue

No. of Sample : 1,209 colorectal cancer (CRC) cases and 1,218 healthy controls

Stage : -

-Polymorhpism-TLR4 polymorphisms may serve as biomarker of disease progression.

showed a significant association of D299G with an increased risk of advanced stage (p?=?0.03). Finally, we observed a positive link between D299G and T399I polymorphisms and CRC patients with lymph node (p=0.00024; p=0.0005, respectively) and metastasis (p?=?0.001; p?=?0.002, respectively).

24705379   2014Cell line : -

Source : Tunisian population

Sample Type : -

No. of Sample : 100 patients with colorectal cancer and 140 healthy controls

Stage : -

Meta-analysisUp-regulation-TLR-4 is a promising potential biomarker for the early diagnosis of CRC.

TLR-4 mRNA and protein levels in CRC patients were higher than those in healthy controls.


Gene Details



Chromosome: 9; NC_000009.11 (120466453..120479769)

View Larger Image
   
Gene Type protein coding
Gene Family CD molecules
Description The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor has been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]  
Chromosome 9
Location 9q33.1
Start 117704175  
End 117717491  
Strand +  
Gene Sequence

   Download   Select all

Length 13317  
OMIM ID 603030   
HGNC ID HGNC:11850   
Unigene ID Hs.174312    
Ensembl ID ENSG00000136869   
PharmGKB ID PA36552   

mRNA Information


mRNA ID NM_003266.3
Exon join(1..391,4025..4144,4389..4555,8215..13317)  
mRNA Sequence

   Download   Select all

Length 5781  



CDS Information


   
Location join(299..391,4389..4555,8215..10474)
CDS Sequence

   Download   Select all

CCDS ID CCDS6818.1



Protein Information


      
Protein IDNP_003257.1
Protein NameToll-like receptor 4
Molecular Wt. (Da)91165
Protein Sequence

   Download   Select all

Length 799  
Uniprot IDP26358
Ensembl Protein ID ENSP00000345739  



Post-translational Modification Information (Source : HPRD)


Residue Type site
NGlycosylation526
NGlycosylation575
SPhosphorylation730
SPhosphorylation690
SPhosphorylation673
SPhosphorylation530

Enzyme Information


No matching records could be found.

PPi Information


(Click to view network : Source STRING)      View   

                                                                                                                                                                     
Interactant Gene ID (Source: HPRD) Gene Symbol HPRD ID Ref Seq ID Technique References
929CD141151NP_000582.1in vivo12196527   
3656IRAK24491NP_001561.3in vivo9625770   
4615MYD883703NP_002459.2in vivo1   095   299   411   743   580   
7096TLR13119NP_003254.2in vivo11932926   
7100TLR54326NP_003259.2in vitro;in vivo12794153   
7184HSP90B11860NP_003290.1in vivo11912201   
8767RIPK24585NP_003812.1in vivo15691841   
8915BCL104625NP_003912.1in vivo15213237   
23162MAPK8IP312014NP_055948.2in vivo12941697   
50507NOX49243NP_058627.1in vitro;yeast 2-hybrid15356101   
245812CNPY414611NP_689968.1in vitro;in vivo16338228   


Pathway Information


                                                                                                                              
Pathway Name Pathway ID
Amoebiasis hsa05146
Chagas disease (American trypanosomiasis) hsa05142
Hepatitis B hsa05161
HIF-1 signaling pathway hsa04066
Inflammatory bowel disease (IBD) hsa05321
Influenza A hsa05164
Legionellosis hsa05134
Leishmaniasis hsa05140
Malaria hsa05144
Measles hsa05162
NF-kappa B signaling pathway hsa04064
Pathogenic Escherichia coli infection hsa05130
Pertussis hsa05133
Phagosome hsa04145
PI3K-Akt signaling pathway hsa04151
Proteoglycans in cancer hsa05205
Rheumatoid arthritis hsa05323
Salmonella infection hsa05132
Toll-like receptor signaling pathway hsa04620
Toxoplasmosis hsa05145
Tuberculosis hsa05152


Structure Information


No matching records could be found.

Domain Information




ID Location Description
pfam01582676-814  TIR
cl22869676-814  TIR_2 superfamily
smart00255674-815  TIR
pfam13676677-781  TIR_2
smart00082579-625  LRRCT
cl15307579-625  LRRCT superfamily
cd00116152-456  LRR_RI
cl23707152-456  LRR_RI superfamily
cd0011655-195  LRR_RI
cl2370755-195  LRR_RI superfamily
cd00116372-581  LRR_RI
cl23707372-581  LRR_RI superfamily
pfam12799150-190  LRR_4
cl19302150-190  LRR_4 superfamily
cd0011659-187  LRR_RI
pfam12799497-538  LRR_4
cl19302497-538  LRR_4 superfamily
pfam1385578-138  LRR_8
pfam13855471-532  LRR_8
pfam13855422-483  LRR_8
pfam13855373-434  LRR_8
PLN0011347-532  PLN00113
COG488628-190  LRR
pfam1385557-114  LRR_8
COG4886344-549  LRR
PLN00113349-556  PLN00113
pfam13855447-508  LRR_8
PLN0011357-627  PLN00113
pfam13855102-187  LRR_8
COG488641-190  LRR
PLN03150487-583  PLN03150
pfam13855152-190  LRR_8
pfam13855399-458  LRR_8
PLN00113468-579  PLN00113
pfam1458041-131  LRR_9


Ontology Information


   
HPRD ID2187
Molecular ClassCell surface receptor
Molecular FunctionPeptidase activity (GO:0008233)
Biological ProcessProtein metabolism (GO:0019538)  



SNP Information


View SNP Geneview Report   

Drug Information


Uniprot ID DrugBank ID Name Type
O00206DB01183NaloxoneSmallMoleculeDrug

External Links


                                 
ArrayExpressGO
ICGCGO
Cancer3DGO
COSMICGO
NCGGO
TSGeneGO
Tumor Gene Family of DatabasesGO
CCDBGO
G2SBCGO
Osteosarcoma DatabaseGO
RCDBGO